Thymoma, Myasthenia Gravis, and Other Paraneoplastic Syndromes

Hematology/Oncology Clinics of North America

Volumn 22, Issue 3, 2008, Pages 509-526

  Tormoehlen, Laura M ^a   Pascuzzi, Robert M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ATROPINE; AZATHIOPRINE; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; DIPHENHYDRAMINE; GLYCOPYRRONIUM BROMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANOPHOSPHORUS COMPOUND; PENICILLAMINE; POTASSIUM SPARING DIURETIC AGENT; PREDNISONE; PYRIDOSTIGMINE; QUINIDINE; QUININE; TELITHROMYCIN;

ABDOMINAL DISCOMFORT; ANOREXIA; ASEPTIC NECROSIS; CATARACT; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; FEVER; GRAFT VERSUS HOST REACTION; HEADACHE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN DEFICIENCY; INTESTINE PSEUDOOBSTRUCTION; LOW DRUG DOSE; MOON FACE; MYASTHENIA GRAVIS; MYOCARDITIS; MYOKYMIA; MYOTONIC DYSTROPHY; NAUSEA; NEPHROTOXICITY; NEUROMUSCULAR TRANSMISSION; OSTEOPOROSIS; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; PURE RED CELL ANEMIA; REVIEW; SIDE EFFECT; STIFF MAN SYNDROME; THYMECTOMY; THYMOMA; UNSPECIFIED SIDE EFFECT;

CHOLINESTERASE INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYASTHENIA GRAVIS; PARANEOPLASTIC SYNDROMES; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS;

EID: 44249102976     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.03.004     Document Type: Review

References (112)

1. Morgenthaler T.I., Brown L.R., Colby T.V., et al. Thymoma. Mayo Clin Proc 68 11 (1993) 1110-1123
2. Lewis J.E., Wick M.R., Scheithauer B.W., et al. Thymoma. A clinicopathologic review. Cancer 60 11 (1987) 2727-2743
3. Evoli A., Minicuci G.M., Vitaliani R., et al. Paraneoplastic diseases associated with thymoma. J Neurol 254 6 (2007) 756-762
4. Monden Y., Uyama T., Nakahara K., et al. Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann Thorac Surg 41 2 (1986) 189-192
5. Howard Jr. F.M., Lenin V.A., Finley J., et al. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci 505 (1987) 526-538
6. Grob D., Arsura E.L., Brunner N.G., et al. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 505 (1987) 472-499
7. Pascuzzi R.M. Medications and myasthenia gravis. Available at:. www.myasthenia.org Accessed January 2007
8. Pascuzzi R.M. The edrophonium test. Semin Neurol 23 1 (2003) 83-88
9. Evoli A., Tonali P.A., Padua L., et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 10 (2003) 2304-2311
10. Sanders D.B., El-Salem K., Massey J.M., et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60 12 (2003) 1978-1980
11. Strauss A.J., and Kemp Jr. P.G. Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s). J Immunol 99 5 (1967) 945-953
12. Pascuzzi R.M. Pearls and pitfalls in the diagnosis and management of neuromuscular junction disorders. Semin Neurol 21 4 (2001) 425-440
13. Oosterhuis H.J. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 52 10 (1989) 1121-1127
14. Bever Jr. C.T., Aquino A.V., Penn A.S., et al. Prognosis of ocular myasthenia. Ann Neurol 14 5 (1983) 516-519
15. Oppenheim H. Weiterer beitrag zur lehre von der acuten, nicht-eitrigen encephalitis und der poliencephalomyelitis. Dtsch Z Nervenheilkd 15 (1899) 1-26 [in German]
16. Lacquer L., and Weigert C. Beitrage zur lehre von der erb'schen. krankheit ueber die erbsche krankheit (myasthenia gravis). Neurologisches Zentralblatt 20 (1901) 594-601 [in German]
17. Buzzard E.F. The clinical history and post-mortem examination of five cases of myasthenia gravis. Brain 28 (1905) 438-483
18. Bell E.J. Tumors of the thymus in myasthenia gravis. J Nerv Ment Dis 45 (1917) 130-143
19. Hammar J.A. Zur histogenese und involution der thymus druse. Anat Anz 27 (1905) 23-30 [in German]
20. Schumacher C., and Roth P. Thymektomie bei einen fall von morbus basedowi mit myasthenia. Mitteilungen Grenzgebiet Medizinische Chirurgie 25 (1913) 746-765 [in German]
21. Haberer H. von.Zur klinischen bedeutung der thymusdruse. Archiv für Klinische Chirurgie 109 (1917) 193-248 [in German]
22. Blalock A., Mason M.F., Morgan H.J., et al. Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed. Ann Surg 110 (1939) 554-561
23. Blalock A. Thymectomy in the treatment of myasthenia gravis: report of 20 cases. J Thorac Surg 13 (1944) 316-339
24. Jaretzki III A., Aarli J.A., Kaminski H.J., et al. Thymectomy for myasthenia gravis: evaluation requires controlled prospective studies. Ann Thorac Surg 76 1 (2003) 1-3
25. Perlo V.P., Arnason B., Poskanzer D., et al. The role of thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci 183 (1971) 308-315
26. Buckingham J.M., Howard F.M., Bernatz P.E., et al. The value of thymectomy in myasthenia gravis: computer assisted match study. Ann Surg 184 4 (1976) 453-458
27. Eaton L.M., and Clagett O.T. Thymectomy in the treatment of myasthenia gravis. Results in 72 cases compared with 142 control cases. JAMA 142 (1950) 963-967
28. Jaretzki III A., Penn A.S., Younger D.S., et al. "Maximal" thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg 95 5 (1988) 747-757
29. Schumm F., Wietholter H., Fateh-Moghadam A., et al. Thymectomy in myasthenia with pure ocular symptoms. J Neurol Neurosurg Psychiatry 48 4 (1985) 332-337
30. Pascuzzi R.M., Coslett H.B., and Johns T.R. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 15 3 (1984) 291-298
31. Ciafaloni E., Massey J.M., Tucker-Lipscomb B., et al. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology 56 1 (2001) 97-99
32. Schneider C., Gold R., Reiners K., et al. Mycophenolate mofetil in the therapy of severe myasthenia gravis. Eur Neurol 46 2 (2001) 79-82
33. Meriggioli M.N., Rowin J., Richman J.G., et al. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Ann N Y Acad Sci 998 (2003) 494-499
34. Sanders, Donald, Siddiqi Z. Lessons from two trials of mycophenolate mofetil in myasthenia gravis. Annals of the New York Academy of Sciences, submitted for publication.
35. Sanders D.B., Hart I.K., Mantegazza R., et al. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology (2008) in press
36. Mertens H.G., Balzereit F., and Leipert M. The treatment of severe myasthenia gravis with immunosuppressive agents. Eur Neurol 2 6 (1969) 321-339
37. Matell G., Bergstrom K., Franksson C., et al. Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci 274 (1976) 659-676
38. Hohlfeld R., Toyka K.V., Besinger U.A., et al. Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine. Ann Neurol 17 3 (1985) 238-242
39. Miano M.A., Bosley T.M., Heiman-Patterson T.D., et al. Factors influencing outcome of prednisone dose reduction in myasthenia gravis. Neurology 41 6 (1991) 919-921
40. Palace J., Newsome-Davis J., and Lecky B. The Myasthenia Gravis Study Group. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology 50 6 (1998) 1778-1783
41. Tindall R.S., Rollins J.A., Phillips J.T., et al. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316 12 (1987) 719-724
42. Tindall R.S., Phillips J.T., Rollins J.A., et al. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann N Y Acad Sci 681 (1993) 539-551
43. Ronager J., Ravnborg M., Hermansen I., et al. Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis. Artif Organs 25 (2001) 967-973
44. Gajdos P., Chevret S., Clair B., et al. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia gravis clinical study group. Ann Neurol 41 6 (1997) 789-796
45. Qureshi A.I., Choudhry M.A., Akbar M.S., et al. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 52 3 (1999) 629-632
46. Thomas C.E., Mayer S.A., Gungor Y., et al. Myasthenic crisis: clinical features, mortality, complications and risk factors for prolonged intubation. Neurology 48 5 (1997) 1253-1260
47. Berrouschot J., Baumann I., Kalischewski P., et al. Therapy of myasthenic crisis. Crit Care Med 25 7 (1997) 1228-1235
48. Zinman L., Ng E., and Bril V. IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial. Neurology 68 11 (2007) 837-841
49. Hartmann C.A., Roth C., Minck C., et al. Thymic carcinoma. Report of five cases and review of the literature. J Cancer Res Clin Oncol 116 1 (1990) 69-82
50. Graus F., Delattre J.Y., Antoine J.Y., et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75 8 (2004) 1135-1140
51. Knudsen A., Bredholt G., Storstein A., et al. Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma. Clin Exp Immunol 149 1 (2007) 16-22
52. Vincent A., Buckley C., Schott J.M., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127 Pt 3 (2004) 701-712
53. Antoine J.C., Honnorat J., Anterion C.T., et al. Limbic encephalitis and immunological perturbations in two patients with thymoma. J Neurol Neurosurg Psychiatry 58 6 (1995) 706-710
54. Cunningham J.D., and Burt M.E. Limbic encephalitis secondary to malignant thymoma. Ann Thorac Surg 58 1 (1994) 250-251
55. Okita K., Matsukawa N., Hattori M., et al. Recurrent limbic and extralimbic encephalitis associated with thymoma. Clin Neurol Neurosurg 109 2 (2007) 206-209
56. Lee E.K., Maselli R.A., Ellis W.G., et al. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry 65 6 (1998) 857-862
57. O'Sullivan S.S., Mullins G.M., Neligan A., et al. Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis. Clin Neurol Neurosurg 109 4 (2007) 374-375
58. Viallard J.F., Vincent A., Moreau J.F., et al. Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction. Eur Neurol 53 2 (2005) 60-63
59. Hayat G.R., Kulkantrakorn K., Campbell W.W., et al. Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy. J Neurol Sci 181 1-2 (2000) 38-43
60. Evoli A., Lo Monaco M., Marra R., et al. Multiple paraneoplastic diseases associated with thymoma. Neuromuscul Disord 9 8 (1999) 601-603
61. Fukushima K., Sato T., Mitsuhashi A., et al. Isaac's syndrome associated with myasthenia gravis, showing remission after cytoreductive surgery of pleural recurrence of thymoma. Neuromuscul Disord 16 11 (2006) 763-765
62. Antelli A., Spengos K., Zambelis T., et al. Neuromyotonia and myasthenia gravis in the absence of thymoma. Eur J Neurol 13 7 (2006) e5
63. Van Parijs V., Van den Bergh P.Y., and Vincent A. Neuromyotonia and myasthenia gravis without thymoma. J Neurol Neurosurg Psychiatry 73 3 (2002) 344-345
64. Heidenreich F., and Vincent A. Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy. Neurology 50 5 (1998) 1483-1485
65. Garcia-Merino A., Cabello A., Mora J.S., et al. Continuous muscle fiber activity, peripheral neuropathy, and thymoma. Ann Neurol 29 2 (1991) 215-218
66. Musthafa C.P., Moosa A., Chandrashekharan P.A., et al. Intestinal pseudo-obstruction as initial presentation of thymoma. Indian J Gastroenterol 25 5 (2006) 264-265
67. Vernino S., Cheshire W.P., and Lennon V.A. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci 88 3 (2001) 187-192
68. Hagiwara H., Enomoto-Nakatani A., Sakai K., et al. Stiff-person syndrome associated with invasive thymoma: a case report. J Neurol Sci 193 1 (2001) 59-62
69. Iwata T., Inoue K., Mizuguchi S., et al. Thymectomy for paraneoplastic stiff-person syndrome associated with invasive thymoma. J Thorac Cardiovasc Surg 132 1 (2006) 196-197
70. Tanaka H., Matsumura A., Okumura M., et al. Stiff man syndrome with thymoma. Ann Thorac Surg 80 2 (2005) 739-741
71. Nicholas A.P., Chatterjee A., Arnold M.M., et al. Stiff-persons' syndrome associated with thymoma and subsequent myasthenia gravis. Muscle Nerve 20 4 (1997) 493-498
72. Kudva G.C., Maliekel K., Kim H.J., et al. Thymoma and myotonic dystrophy: successful treatment with chemotherapy and radiation: case report and review of the literature. Chest 121 6 (2002) 2061-2063
73. Mathieu J., Allard P., Gobeil G., et al. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 49 6 (1997) 1646-1650
74. Tanahashi N., Sato H., Nogawa S., et al. A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis. Keio J Med 53 1 (2004) 30-42
75. Otton S.H., Standen G.R., and Ormerod I.E. T cell lymphocytosis associated with polymyositis, myasthenia gravis and thymoma. Clin Lab Haematol 22 5 (2000) 307-308
76. Ko K.F., Ho T., and Chan K.W. Autoimmune chronic active hepatitis and polymyositis in a patient with myasthenia gravis and thymoma. J Neurol Neurosurg Psychiatry 59 5 (1995) 558-559
77. Cranney A., Markman S., Lach B., et al. Polymyositis in a patient with thymoma and T cell lymphocytosis. J Rheumatol 24 7 (1997) 1413-1416
78. Katabami S., Sugiyama T., Kodama T., et al. Polymyositis associated with thymoma and the subsequent development of pure red cell aplasia. Intern Med 34 6 (1995) 569-573
79. Gidron A., Quadrini M., Dimov N., et al. Malignant thymoma associated with fatal myocarditis and polymyositis in a 32-year-old woman with a history of hairy cell leukemia. Am J Clin Oncol 29 2 (2006) 213-214
80. Pentz W.H. Advanced heart block as a manifestation of a paraneoplastic syndrome from malignant thymoma. Chest 116 4 (1999) 1135-1136
81. Glennon P.E., Petersen M.E., and Sheppard M.N. Fatal giant cell myocarditis after resection of thymoma. Heart 75 5 (1996) 531-532
82. Sader C., Sharma S., and Edwards M.G. Graft-versus-host disease-type colitis: an unusual association of malignant thymoma. Ann Thorac Surg 73 6 (2002) 1947-1948
83. Sleijfer S., Kaptein A., Versteegh M.I., et al. Full-blown graft-versus-host disease presenting with skin manifestations, jaundice and diarrhoea: an unusual paraneoplastic phenomenon of a thymoma. Eur J Gastroenterol Hepatol 15 5 (2003) 565-569
84. Wadhera A., Maverakis E., Mitsiades N., et al. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. J Am Acad Dermatol 57 4 (2007) 683-689
85. Cucchiara B.L., Forman M.S., McGarvey M.L., et al. Fatal subacute cytomegalovirus encephalitis associated with hypogammaglobulinemia and thymoma. Mayo Clin Proc 78 2 (2003) 223-227
86. Davila D.G., and Ryan D.H. Thymoma, hypogammaglobulinemia, and pernicious anemia. South Med J 79 7 (1986) 904-906
87. Hon C., Chui W.H., Cheng L.C., et al. Thymoma associated with keratoconjunctivitis, lichen planus, hypogammaglobinemia, and absent circulating B cells. J Clin Oncol 24 18 (2006) 2960-2961
88. Ishibashi H., Akamatsu H., Kojima K., et al. Good syndrome with thymic adenosquamous carcinoma-report of a case. Ann Thorac Cardiovasc Surg 13 1 (2007) 50-52
89. Raschal S., Siegel J.N., Huml J., et al. Hypogammaglobulinemia and anemia 18 years after thymoma resection. J Allergy Clin Immunol 100 6 Pt 1 (1997) 846-848
90. Verne G.N., Amann S.T., Cosgrove C., et al. Chronic diarrhea associated with thymoma and hypogammaglobulinemia (Good's syndrome). South Med J 90 4 (1997) 444-446
91. Rosenow III E.C., and Hurley B.T. Disorders of the thymus. A review. Arch Intern Med 144 4 (1984) 763-770
92. Bailey R.O., Dunn H.G., Rubin A.M., et al. Myasthenia gravis with thymoma and pure red blood cell aplasia. Am J Clin Pathol 89 5 (1988) 687-693
93. Fujisao S., and Tsuda H. Th1/Th2 balance alteration in the clinical course of a patient with pure red cell aplasia and thymoma. Br J Haematol 103 2 (1998) 308-310
94. Anderson N.E., Hutchinson D.O., Nicholson G.J., et al. Intestinal pseudo-obstruction, myasthenia gravis, and thymoma. Neurology 47 4 (1996) 985-987
95. Pande R., and Leis A.A. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 22 11 (1999) 1600-1602
96. Murao S., Yoshinouchi T., Sato M., et al. Silent thyroiditis after excision of a thymoma. Intern Med 37 7 (1998) 604-605
97. Yoshidome Y., Hayashi S., Maruyama Y., et al. A case of mixed connective tissue disease complicated with thymic carcinoma and Hashimoto's thyroiditis. Mod Rheumatol 17 1 (2007) 63-66
98. Lin Y.-C., Wu C.-C., Ou T.-T., et al. Malignant thymoma associated with mixed connective tissue disease: a case report. Clin Rheumatol 25 2 (2006) 262-264
99. Palmieri G., Selleri C., Montella L., et al. Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ t lymphocytes. Am J Hematol 81 10 (2006) 774-778
100. Chave T.A., Bamford W.M., and Harman K.E. Acrokeratosis paraneoplastica associated with recurrent metastatic thymic carcinoma. Clin Exp Dermatol 29 4 (2004) 430-432
101. Boonen A., Rennenberg R., and van der Linden S. Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature. Rheumatology 39 9 (2000) 1044-1046
102. Bozzolo E., Bellone M., Quaroni N., et al. Thymoma associated with systemic lupus erythematosus and immunologic abnormalities. Lupus 9 2 (2000) 151-154
103. Rakfal S.M., and Deutsch M. Radiotherapy for malignancies associated with lupus: case reports of acute and late reactions. Am J Clin Oncol 21 1 (1998) 54-57
104. Favia G.F., Di Alberti L., and Piattelli A. Paraneoplastic pemphigus: a report of two cases. Oral Oncol 34 6 (1998) 571-575
105. Hartz R.S., and Daroca P.J. Clinical-pathologic conference: cutaneous paraneoplastic pemphigus associated with benign encapsulated thymoma. J Thorac Cardiovasc Surg 125 2 (2003) 400-406
106. Meyer S., Kroiss M., Landthaler M., et al. Thymoma, myasthenia gravis, eruptions of pemphigus vulgaris and a favourable course of relapsing melanoma: an immunological puzzle. Br J Dermatol 155 3 (2006) 638-640
107. Wang J., Bu D.F., Li T., et al. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 153 3 (2005) 558-564
108. Bobbio A., Vescovi P., Ampollini L., et al. Oral erosive lichen planus regression after thymoma resection. Ann Thorac Surg 83 3 (2007) 1197-1199
109. Hahn J.M., Meisler D.M., Lowder C.Y., et al. Cicatrizing conjunctivitis associated with paraneoplastic lichen planus. Am J Ophthalmol 129 1 (2000) 98-99
110. Mineo T.C., Biancari F., and D'Andrea V. Myasthenia gravis, psychiatric disturbances, idiopathic thrombocytopenic purpura, and lichen planus associated with cervical thymoma. J Thorac Cardiovasc Surg 111 2 (1996) 486-487
111. Katsuta H., Okada M., Nakauchi T., et al. Cancer-associated retinopathy associated with invasive thymoma. Am J Ophthalmol 134 3 (2002) 383-389
112. Yamada G., Ohguro H., Aketa K., et al. Invasive thymoma with paraneoplastic retinopathy. Hum Pathol 34 7 (2003) 717-719